Adial Pharmaceuticals, Inc. (ADIL)
6.65
-0.47
(-6.60%)
USD |
NASDAQ |
Sep 08, 16:00
6.65
0.00 (0.00%)
Pre-Market: 09:15
Adial Pharmaceuticals Shareholders Equity (Quarterly) : -38.38M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -38.38M |
| March 31, 2026 | 3.717M |
| December 31, 2025 | 5.276M |
| September 30, 2025 | 4.505M |
| June 30, 2025 | 5.591M |
| March 31, 2025 | 2.127M |
| December 31, 2024 | 4.068M |
| September 30, 2024 | 5.884M |
| June 30, 2024 | 4.277M |
| March 31, 2024 | 6.122M |
| December 31, 2023 | 4.084M |
| September 30, 2023 | 2.339M |
| June 30, 2023 | 3.317M |
| March 31, 2023 | 1.440M |
| December 31, 2022 | 3.276M |
| September 30, 2022 | 5.409M |
| June 30, 2022 | 7.961M |
| March 31, 2022 | 10.71M |
| December 31, 2021 | 3.508M |
| September 30, 2021 | 7.200M |
| Date | Value |
|---|---|
| June 30, 2021 | 4.829M |
| March 31, 2021 | 5.618M |
| December 31, 2020 | 3.986M |
| September 30, 2020 | 7.085M |
| June 30, 2020 | 8.793M |
| March 31, 2020 | 5.551M |
| December 31, 2019 | 7.141M |
| September 30, 2019 | 8.73M |
| June 30, 2019 | 10.06M |
| March 31, 2019 | 11.73M |
| December 31, 2018 | 4.441M |
| September 30, 2018 | 4.929M |
| June 30, 2018 | -1.294M |
| March 31, 2018 | -1.307M |
| December 31, 2017 | -0.9976M |
| September 30, 2017 | -0.6643M |
| June 30, 2017 | -0.4655M |
| March 31, 2017 | -0.2437M |
| December 31, 2016 | -0.1035M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Eli Lilly & Co. | 33.88B |
| ANI Pharmaceuticals, Inc. | 597.21M |
| Corcept Therapeutics, Inc. | 705.78M |
| Veru, Inc. | 28.38M |
| Johnson & Johnson | 84.97B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 29.09M |
| Total Liabilities (Quarterly) | 67.47M |
| Debt to Equity Ratio | -1.624 |
| Current Ratio | 5.633 |
| Net Debt Paydown Yield | -185.5% |